• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Investigation of a Cluster of Severe Respiratory Disease Referred from Uganda to Kenya, February 2017

tetano

Editor, Senior Moderator
Health Secur. 2020 Mar/Apr;18(2):96-104. doi: 10.1089/hs.2019.0107.
Investigation of a Cluster of Severe Respiratory Disease Referred from Uganda to Kenya, February 2017.


Okello PE[SUP]1[/SUP], Majwala RK[SUP]1[/SUP], Kalani R[SUP]1[/SUP], Kwesiga B[SUP]1[/SUP], Kizito S[SUP]1[/SUP], Kabwama SN[SUP]1[/SUP], Bulage L[SUP]1[/SUP], Ndegwa LK[SUP]1[/SUP], Ochieng M[SUP]1[/SUP], Harris JR[SUP]1[/SUP], Hunsperger E[SUP]1[/SUP], Kajumbula H[SUP]1[/SUP], Kadobera D[SUP]1[/SUP], Zhu BP[SUP]1[/SUP], Chaves SS[SUP]1[/SUP], Ario AR[SUP]1[/SUP], Widdowson MA[SUP]1[/SUP].

Author information




Abstract

On February 22, 2017, Hospital X-Kampala and US CDC-Kenya reported to the Uganda Ministry of Health a respiratory illness in a 46-year-old expatriate of Company A. The patient, Mr. A, was evacuated from Uganda to Kenya and died. He had recently been exposed to dromedary camels (MERS-CoV) and wild birds with influenza A (H5N6). We investigated the cause of illness, transmission, and recommended control. We defined a suspected case of severe acute respiratory illness (SARI) as acute onset of fever (≥38?C) with sore throat or cough and at least one of the following: headache, lethargy, or difficulty in breathing. In addition, we looked at cases with onset between February 1 and March 31 in a person with a history of contact with Mr. A, his family, or other Company A employees. A confirmed case was defined as a suspected case with laboratory confirmation of the same pathogen detected in Mr. A. Influenza-like illness was defined as onset of fever (≥38?C) and cough or sore throat in a Uganda contact, and as fever (≥38?C) and cough lasting less than 10 days in a Kenya contact. We collected Mr. A's exposure and clinical history, searched for cases, and traced contacts. Specimens from the index case were tested for complete blood count, liver function tests, plasma chemistry, Influenza A(H1N1)pdm09, and MERS-CoV. Robust field epidemiology, laboratory capacity, and cross-border communication enabled investigation.



KEYWORDS:

Influenza-like illness; Kenya; Respiratory illness; Severe acute respiratory illness; Uganda


PMID:32324075DOI:10.1089/hs.2019.0107
 
Back
Top Bottom